- $90.92bn
- $114.89bn
- $247.12bn
- 94
- 66
- 62
- 88
Annual balance sheet for Cigna, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11,513 | 6,001 | 6,829 | 8,747 | 8,215 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12,191 | 15,071 | 17,218 | 17,722 | 24,227 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 27,799 | 36,134 | 30,122 | 37,351 | 48,870 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,757 | 4,143 | 3,774 | 4,065 | 3,654 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 155,451 | 154,889 | 143,885 | 152,761 | 155,881 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 36,022 | 43,572 | 41,225 | 48,716 | 57,979 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 105,130 | 107,777 | 99,210 | 106,538 | 114,848 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 50,321 | 47,112 | 44,675 | 46,223 | 41,033 |
Total Liabilities & Shareholders' Equity | 155,451 | 154,889 | 143,885 | 152,761 | 155,881 |
Total Common Shares Outstanding |